Jacobson Pharma will conduct an IPO of its subsidiary JBM Healthcare. Currently, Jacobson Pharma owns 85.04% of JBM shares. It is planned to keep at least 50% of the company's shares after the IPO. JBM is a medical company producing branded health products in China, Southeast Asia and some other countries.